News

Drug Approvals Hit an FDA Wall

Therapies for rare and deadly disease are dying in Marty Makary’s shop.
BioSpace8h

Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues

CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
Infectious Disease Advisor8h

Vinay Prasad Returns to FDA After Being Ousted

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
MedPage Today10h

Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
Northwest Asian Weekly1d

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
JD Supra1d

The Return of CBER Director Prasad, FDA Announces New Chief Counsel, and FDA Budget Watch

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
STAT1d

Prasad returns to the FDA, Attack on the CDC

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...